#China #Beijing #MediThinQ #Sinopharm #Scopeye

MediThinQ Partners with Sinopharm

MediThinQ, a pioneering South Korean firm specializing in wearable extended reality (XR) surgical displays, is making a significant leap into the Chinese healthcare sector through a strategic alliance with Sinopharm — a leading state-owned healthcare provider in China and the largest distributor of pharmaceuticals and medical equipment in the nation.

This partnership includes the exclusive distribution of MediThinQ's flagship product, Scopeye, throughout China, a move that is set to revolutionize how surgeons access critical information during surgeries. The introduction of Scopeye into major Chinese hospitals, facilitated by Sinopharm's extensive healthcare network, promises to enhance the precision and efficiency of surgical procedures by providing surgeons with uninterrupted access to real-time, high-definition data.

MediThinQ's innovative XR solutions are the first of their kind created specifically for live surgical environments. With the ability to stream information and images directly into the surgeon's line of sight, this groundbreaking technology allows for improved concentration and reduces the need for surgeons to divert their gaze away from the operation.

The company has already secured regulatory approvals in major markets, including the U.S., Europe, and South Korea, and has successfully conducted over 10,000 tests and live demonstrations across various hospitals. This level of validation highlights the company's commitment to redefining surgical practices globally.

Seungjoon Im, the company's founder and CEO, expressed great enthusiasm regarding the partnership: "With Sinopharm as our robust ally, we are eager to introduce this transformative technology to surgeons in China and speed up its implementation. This step marks just the start of our efforts in China, and we look forward to collaborating with Sinopharm on advancing our innovations further."

Wang Yiran, Chairman of Sinopharm Group Med-Tech Co., Ltd., added, "As a leader in adopting cutting-edge medical technology in China, we are pleased to distribute MediThinQ's XR surgical displays, which will elevate ergonomics for healthcare practitioners and enhance operating room efficiency. This innovation is set to not only refine surgical procedures but also change how surgical professionals train and learn."

The partnership's potential is amplified by the backing of VentureBlick, a key player in global healthcare innovation. Chris Lee, Founder and CEO of VentureBlick, stated, "Our mission has always been to elevate local medical technologies onto the international stage, and MediThinQ’s expansion from the U.S. to Europe and now into China exemplifies this goal in action."

Recent advancements, including breakthroughs in products like the world’s smallest portable 3D microscope and a superior digital loupe, signal MediThinQ's strong commitment to research and development. Following a successful Series B funding round that raised $8.8 million, the company's new collaboration in China is poised to solidify its role as a leader in the global medical technology landscape.

This development not only fills a crucial gap in MediThinQ's worldwide strategy but also catalyzes the integration of innovative surgical solutions into China's expansive healthcare system. As the usage of wearable surgical displays becomes a standard practice, the implications for improved patient outcomes and surgical training are profound.

With this noteworthy partnership, MediThinQ sets the stage for a new era in surgical excellence and continues its mission of enhancing healthcare through innovative technologies.